News for Verrica Pharmaceuticals Inc Stock (VRCA)

VRCA LAWSUIT ALERT: Levi & Korsinsky Notifies Verrica Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

PRNewsWire • 08/04/22

Verrica Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before August 5, 2022 to Discuss Your Rights - VRCA

Newsfile Corp • 08/04/22

FRIDAY DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 08/03/22

INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm

Business Wire • 08/03/22

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Verrica Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 5, 2022 - (NASDAQ: VRCA)

PRNewsWire • 08/03/22

VRCA Investors Have Opportunity to Lead Verrica Pharmaceuticals Inc. Securities Fraud Lawsuit

PRNewsWire • 08/02/22

FRIDAY DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 08/02/22

VRCA ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 5, 2022 in the Class Action Filed on Behalf of Verrica Pharmaceuticals, Inc. Shareholders

PRNewsWire • 08/02/22

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verrica Pharmaceuticals, Inc. -VRCA

PRNewsWire • 08/01/22

Verrica Pharmaceuticals Announces Start of Phase 3 Trial of VP-102 for the Treatment of Molluscum Contagiosum by Torii Pharmaceutical Co., Ltd. in Japan

GlobeNewsWire • 08/01/22

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Verrica Investors of a Lead Plaintiff Deadline of August 5, 2022

PRNewsWire • 08/01/22

VRCA INVESTOR NOTICE: ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Verrica Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important August 5 Deadline in Securities Class Action - VRCA

PRNewsWire • 07/31/22

ROSEN, Leading Investor Counsel, Encourages Verrica Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important August 5 Deadline in Securities Class Action - VRCA

Newsfile Corp • 07/29/22

Verrica Class Action: Levi & Korsinsky Reminds Verrica Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 5, 2022 - VRCA

Newsfile Corp • 07/28/22

ROSEN, National Trial Lawyers, Encourages Verrica Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important August 5 Deadline in Securities Class Action - VRCA

Newsfile Corp • 07/28/22

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 07/25/22

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Verrica Pharmaceuticals Inc. Investors With Losses to Secure Counsel Before Important August 5 Deadline in Securities Class Action - VRCA

Newsfile Corp • 07/24/22

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Verrica Pharmaceuticals Inc. Investors to Secure Counsel Before Important August 5 Deadline in Securities Class Action - VRCA

PRNewsWire • 07/23/22

VRCA ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 5, 2022 in the Class Action Filed on Behalf of Verrica Pharmaceuticals, Inc. Limited Shareholders

Newsfile Corp • 07/22/22

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 07/22/22

ROSEN, National Trial Lawyers, Encourages Verrica Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - VRCA

Newsfile Corp • 07/20/22

Berger Montague Investigates Securities Fraud Allegations Against Verrica Pharmaceuticals, Inc. (NASDAQ: VRCA) - VERRICA PHARMACEUTICALS, INC. - Lead Plaintiff Deadline is August 5, 2022

PRNewsWire • 07/20/22

Verrica Pharmaceuticals Inc. (VRCA) Upgraded to Strong Buy: What Does It Mean for the Stock?

Zacks Investment Research • 07/20/22

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 07/20/22

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Verrica Pharmaceuticals, Inc. -VRCA

Newsfile Corp • 07/19/22